ARTICLE | Management Tracks
Faces in new places ahead of JPM: Rubin joining Guggenheim
Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more
January 11, 2025 3:15 AM UTC
Former top equity analyst, VC and biopharma CFO Jami Rubin and longtime biotech CEO Mitchell Gold were among the dozens of executives and investors on the move on the eve of the annual J.P. Morgan Healthcare Conference in San Francisco.
The announcements included moves at Beigene, Centessa and newly public Septerna, among many others; a retirement at Intellia; and a new partner at Nutter McClennen & Fish...